VitaSpring Biomedical Co. Ltd. (VSBC)

USD 16.0

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - 5.61 Million 248.2 Thousand 15.14 Thousand 17.18 Thousand 16.23 Thousand
Cost of Revenue - 3.54 Million 136 Thousand 13.44 Thousand 3912.00 5264.00
Gross Profit - 2.06 Million 112.2 Thousand 1695.00 13.26 Thousand 10.96 Thousand
Operating Expenses - 584.53 Thousand 536.91 Thousand 21.18 Thousand 34.6 Thousand 16.74 Thousand
Selling, General and Administrative Expenses - 568.92 Thousand 536.11 Thousand 20.73 Thousand 34.6 Thousand 16.74 Thousand
Research and Development Expenses - - - - - -
Other Expenses - 15.6 Thousand 800.00 450.00 - -
Cost and Expenses - 4.12 Million 672.91 Thousand 34.62 Thousand 38.51 Thousand 22.01 Thousand
Operating Income - 1.48 Million -425.38 Thousand -19.48 Thousand -21.33 Thousand -5780.00
Interest Expense - 2360.00 670.00 - - -
Income Tax Expense - 217.1 Thousand -672.00 -17.37 Thousand -171.41 Thousand 1.00
Earnings before Tax - 1.48 Million -425.38 Thousand 6919.00 -22.39 Thousand -6374.00
Net Income - 1.26 Million -425.38 Thousand 24.29 Thousand -22.39 Thousand -6374.00
Earnings Per Share Basic - 0.01 -0.00 0.00 -0.00 -0.00
Earnings Per Share Diluted - 0.01 -0.00 0.00 -0.00 -0.00
Weighted Average Shares Outstanding - 205.98 Million 91.09 Million 54.51 Million 25.15 Million 11.46 Million
Weighted Average Shares Outstanding (Diluted) - 205.98 Million 91.09 Million 54.51 Million 25.15 Million 11.46 Million
Gross Margin - 0.37 0.45 0.11 0.77 0.68
EBIT Margin - 0.27 -1.71 -2.40 -1.22 -0.33
Profit Margin - 0.23 -1.71 1.60 -1.30 -0.39
EBITDA - 1.49 Million -424.71 Thousand -19.03 Thousand -21.94 Thousand -6374.00
Earnings Before Tax Margin - 0.26 -1.71 -1.29 -1.24 -0.36

Income Statement Charts